Furthermore, the BDNF pro-peptide was detected in cerebrospinal fluid, and the content was reduced in samples from patients with depression and schizophrenia [17], indicating that the BDNF research, including our studies, might contribute to the treatment and diagnosis of brain disorders. This evidence concerns the gene BDNF and schizophrenia.